Patent · US Active

Designed ankyrin repeat proteins binding to hepatocyte growth factor

US11453708B2 · kind B2 · utility

2Cited by
7References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2014
Grant dateSep 27, 2022
Priority date
Expiry dateJun 2, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2318/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

New designed ankyrin repeat proteins with binding specificity for HGF are described, as well as nucleic acids encoding such HGF binding proteins, pharmaceutical compositions comprising such proteins and the use of such proteins in the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.